Approaches of increasing oral bioavailability of class ii active pharmaceutical ingredients in accordance with the biopharmaceutical classification system

Journal Title: Вісник фармації - Year 2019, Vol 98, Issue 2

Abstract

Aim. To compare existing approaches used for enhancing oral bioavailability (BA) of class II active pharmaceutical ingredients (API) and categorize them in the order of most promising. Materials and methods. The material of the article was literary data about approaches used for enhancing oral bioavailability of class II active pharmaceutical ingredients with a high permeability and poor solubility. Methods of information search, methods of comparison and generalization, systematic methods were used to carry out the research tasks. Results and discussion. During last 20 years, the share of class II API in accordance with the biopharmaceutical classification system (i.e. with low solubility and high permeability) is continuously increasing at the world market and different stages of pharmaceutical product development. The approaches to improving oral BA of class II API which can be used to develop generic and modified generic drugs have been discussed in this article. These approaches were considered from the point of view of the principle of increasing the oral BA. It is concluded that promising approaches to increase oral BA should meet the following requirements: rapid achievement of oversaturated API concentration and its subsequent maintenance, keeping the whole API dose dissolved during transit through the intestines. Increased solubility and specific surface area are used as the main levers in all these approaches to improve oral bioavailability. At the same time, the ability to form supersaturated solutions and the retention of high concentrations during transit through the intestine differs depending on the approach. Conclusions. The most promising approaches to increase oral bioavailability, contributing to the formation of supersaturated solutions and maintaining high concentrations during transit are included: solid amorphous dispersions of API; digestible formulations that form micelles/emulsions in the intestine; and digestible inclusion complexes with cyclodextrins.

Authors and Affiliations

V. V. Mohylyuk, L. L. Davtian, D. O. Novykov, M. G. Katynska, Yu. V. Shmyrova, O. O. Dobrovolnyi

Keywords

Related Articles

Система медицинского снабжения Вооружённых Сил Украины: фокус на интеграцию

Целью работы является определение актуальных направлений развития системы медицинского снабжения Вооружённых Сил (ВС) Украины в соответствии с созданной единой системой логистического обеспечения ВС Украины. Материалы и...

Исследование антимикробной активности производных этилен-N,N’ бис(спироиндол-3,3’-пирроло[3,4-с]пиррол-2а’,5а’-дигидро-2,2’,6’(1H,1’H,5’H)-триона)

Цель работы – обнаружение соединений с антимикробной активностью в ряду производных этилен-N,N’-бис(спироиндол-3,3’-пирроло[3,4-с]пиррол-2а’,5а’-дигидро-2,2’,6’(1H,1’H,5’H)-триона).Материалы и методы. Исследование антими...

The study of the carbohydrate composition of hawthorn fruits

Carbohydrates, in particular monosaccharides, are necessary for the normal functioning of the human body. Therefore, the search for plant sources of available carbohydrates, such as glucose, fructose, arabinose, is relev...

Вплив екстракту капусти городньої на структурні компоненти клітин слизової оболонки шлунка при її виразковому ураженні

Мета – дослідження впливу екстракту капусти городньої на загальний склад білків та ліпідів клітин слизової оболонки шлунка при експериментальній виразці. Матеріали та методи. На моделі спирто-преднізолонової виразки у щу...

Перспективи створення противірусного лікарського препарату на основі сировини синтетичного походження

Мета роботи. Визначення перспективи створення лікарського препарату на основі інозину пранобексу шляхом наукового аналізу характеристики та асортименту противірусних препаратів на фармацевтичному ринку України. Матеріали...

Download PDF file
  • EP ID EP657584
  • DOI 10.24959/nphj.19.14
  • Views 104
  • Downloads 0

How To Cite

V. V. Mohylyuk, L. L. Davtian, D. O. Novykov, M. G. Katynska, Yu. V. Shmyrova, O. O. Dobrovolnyi (2019). Approaches of increasing oral bioavailability of class ii active pharmaceutical ingredients in accordance with the biopharmaceutical classification system. Вісник фармації, 98(2), 29-35. https://europub.co.uk/articles/-A-657584